Molecular monitoring of response to imatinib (Glivec) in chronic myeloid leukemia patients: experience at a tertiary care hospital in Saudi Arabia. [electronic resource]
Producer: 20100525Description: 67-74 p. digitalISSN:- 1945-0257
- Adolescent
- Adult
- Aged
- Base Sequence
- Benzamides
- Biomarkers, Tumor -- genetics
- Child
- Child, Preschool
- DNA Primers -- genetics
- DNA, Neoplasm -- genetics
- Drug Resistance, Neoplasm
- Female
- Fusion Proteins, bcr-abl -- genetics
- Genes, abl
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Mutation
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Retrospective Studies
- Saudi Arabia
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.